PFCS
Pale Fire Capital SE Portfolio holdings
AUM
$958M
1-Year Return
80.1%
This Quarter Return
+7.68%
1 Year Return
+80.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$887M
AUM Growth
+$169M
(+24%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
13.48%
Top 10 Holdings %
Top 10 Hldgs %
92.83%
Holding
65
New
13
Increased
11
Reduced
11
Closed
16
Top Buys
| 1 |
AT&T
T
|
+$200M |
| 2 |
B2Gold
BTG
|
+$52.2M |
| 3 |
Dole
DOLE
|
+$6.48M |
| 4 |
Warner Bros
WBD
|
+$3.27M |
| 5 |
Teladoc Health
TDOC
|
+$2.93M |
Top Sells
| 1 |
Alibaba
BABA
|
+$32.6M |
| 2 |
Shell
SHEL
|
+$31M |
| 3 |
Scorpio Tankers
STNG
|
+$20M |
| 4 |
International Seaways
INSW
|
+$19.2M |
| 5 |
Vodafone
VOD
|
+$11.4M |
Sector Composition
| 1 | Communication Services | 42.48% |
| 2 | Energy | 30.93% |
| 3 | Consumer Staples | 12.35% |
| 4 | Materials | 8.1% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mineralys Therapeutics
MLYS
$2.88B
| $408K | 0.05% |
34,888
+5,973
| +21% | +$69.9K |
|
27
uniQure
QURE
$904M
| $294K | 0.03% |
65,600
| – | – |
|
28
Celcuity
CELC
$2.33B
| $191K | 0.02% |
11,653
+1,384
| +13% | +$22.7K |
|
29
Black Diamond Therapeutics
BDTX
$185M
| $182K | 0.02% |
39,000
+5,303
| +16% | +$24.7K |
|
|
INZY
30
DELISTED
Inozyme Pharma
INZY
| $173K | 0.02% |
+38,901
| New | +$173K |
|
|
CMRX
31
DELISTED
Chimerix, Inc.
CMRX
| $146K | 0.02% |
166,207
+61,411
| +59% | +$53.8K |
|
32
Immatics
IMTX
$707M
| $134K | 0.02% |
+11,524
| New | +$134K |
|
33
TScan Therapeutics
TCRX
$99.9M
| $126K | 0.01% |
21,573
| – | – |
|
34
Iovance Biotherapeutics
IOVA
$821M
| $118K | 0.01% |
14,700
+3,700
| +34% | +$29.7K |
|
35
ReNew
RNW
$2.76B
| $110K | 0.01% |
17,621
-52,830
| -75% | -$330K |
|
36
Larimar Therapeutics
LRMR
$336M
| $104K | 0.01% |
+14,292
| New | +$104K |
|
37
X4 Pharmaceuticals
XFOR
$73.2M
| $103K | 0.01% |
5,901
+4,632
| +365% | +$80.6K |
|
38
Compass Therapeutics
CMPX
$613M
| $82.8K | 0.01% |
82,777
-43,191
| -34% | -$43.2K |
|
|
ODV
39
Osisko Development Corp
ODV
$733M
| $65.2K | 0.01% |
+35,060
| New | +$65.2K |
|
40
Caribou Biosciences
CRBU
$168M
| $64.1K | 0.01% |
39,107
+17,407
| +80% | +$28.5K |
|
41
RAPT Therapeutics
RAPT
$268M
| $49K | 0.01% |
+2,009
| New | +$49K |
|
42
Lloyds Banking Group
LYG
$67B
| $36.9K | ﹤0.01% |
+13,510
| New | +$36.9K |
|
43
ATAI Life Sciences
ATAI
$992M
| $33K | ﹤0.01% |
+24,784
| New | +$33K |
|
44
Anavex Life Sciences
AVXL
$805M
| – | – |
0
| – | – |
|
|
45
Alibaba
BABA
$370B
| – | – |
-450,000
| Closed | -$32.6M |
|
46
Cidara Therapeutics
CDTX
$1.66B
| – | – |
-3,327
| Closed | -$61.2K |
|
47
Cenovus Energy
CVE
$30.4B
| – | – |
-100,000
| Closed | -$2M |
|
48
Erasca
ERAS
$443M
| – | – |
-111,906
| Closed | -$231K |
|
49
Fortuna Silver Mines
FSM
$2.56B
| – | – |
-140,000
| Closed | -$522K |
|
50
Humacyte
HUMA
$233M
| – | – |
0
| – | – |
|